Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

The CEO will know at the end of the meeting those conditions and designations the FDA has approved. He will be able to report that the E-o-P 2 meeting was successful and that B-OM will advance to Phase 3. He will also be able to report such things as fast-track or any other elements of accelerated approval agreed upon. He may even be able to include any other designation accepted, but not details.

IPIX officers will walk away from the meeting with a good understanding of the outcomes, but not any final details for what the FDA will require in the final protocol.